Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FTRE NASDAQ:SBC NASDAQ:SERA NASDAQ:TALK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFTREFortrea$4.68-0.3%$4.95$3.97▼$27.99$425.80M1.761.96 million shs202,497 shsSBCSBC Medical Group$5.37-5.0%$4.52$2.62▼$12.50$556.18M1.2774,041 shs101,776 shsSERASera Prognostics$2.89-1.0%$2.16$1.37▼$9.13$109.62M0.99178,271 shs6,868 shsTALKTalkspace$2.57+3.4%$2.88$1.60▼$4.36$427.50M1.071.90 million shs415,036 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFTREFortrea0.00%-8.22%-11.84%-9.81%-81.98%SBCSBC Medical Group0.00%+11.88%+31.09%+37.47%+564,999,900.00%SERASera Prognostics0.00%+2.82%+52.08%-13.86%-62.56%TALKTalkspace0.00%-6.06%-7.46%-3.88%+17.54%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFTREFortrea3.7283 of 5 stars3.91.00.00.01.70.83.8SBCSBC Medical GroupN/AN/AN/AN/AN/AN/AN/AN/ASERASera Prognostics0.2584 of 5 stars0.02.00.00.00.62.50.0TALKTalkspace3.7073 of 5 stars3.53.00.00.02.23.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFTREFortrea 1.86Reduce$14.00199.47% UpsideSBCSBC Medical Group 0.00N/AN/AN/ASERASera Prognostics 0.00N/AN/AN/ATALKTalkspace 3.00Buy$4.5075.44% UpsideCurrent Analyst Ratings BreakdownLatest SERA, FTRE, TALK, and SBC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/11/2025FTREFortreaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$8.00 ➝ $7.007/9/2025FTREFortreaEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$6.00 ➝ $5.005/22/2025FTREFortreaCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral5/14/2025FTREFortreaCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold5/14/2025FTREFortreaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.005/14/2025FTREFortreaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$7.00 ➝ $5.005/13/2025FTREFortreaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$6.00 ➝ $5.005/6/2025TALKTalkspaceNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold5/2/2025FTREFortreaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold$7.00(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFTREFortrea$2.70B0.16$1.57 per share2.98$15.19 per share0.31SBCSBC Medical Group$205.42M2.71$0.58 per share9.32$1.90 per share2.83SERASera Prognostics$80K1,361.77N/AN/A$1.40 per share2.07TALKTalkspace$187.59M2.29$0.01 per share208.73$0.69 per share3.72Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFTREFortrea-$328.50M-$8.79N/A3.650.32-29.43%2.84%1.06%8/6/2025 (Estimated)SBCSBC Medical Group$46.61MN/A0.000.96N/AN/A26.72%19.60%8/21/2025 (Estimated)SERASera Prognostics-$32.90M-$0.94N/AN/AN/A-28,685.22%-51.35%-37.21%8/6/2025 (Estimated)TALKTalkspace$1.15M$0.02127.8113.50N/A1.51%2.54%2.15%8/5/2025 (Estimated)Latest SERA, FTRE, TALK, and SBC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025FTREFortrea$0.06N/AN/AN/A$631.61 millionN/A8/6/2025Q2 2025SERASera Prognostics-$0.21N/AN/AN/AN/AN/A8/5/2025Q2 2025TALKTalkspace$0.01N/AN/AN/A$54.08 millionN/A5/15/2025Q1 2025SBCSBC Medical Group$0.11$0.21+$0.10$0.21$51.52 million$47.33 million5/14/2025Q1 2025SERASera Prognostics-$0.24-$0.20+$0.04-$0.20$0.06 million$0.04 million5/12/2025Q1 2025FTREFortrea-$0.07$0.02+$0.09-$6.25$609.63 million$651.30 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFTREFortreaN/AN/AN/AN/AN/ASBCSBC Medical GroupN/AN/AN/AN/AN/ASERASera PrognosticsN/AN/AN/AN/AN/ATALKTalkspaceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFTREFortrea1.220.970.97SBCSBC Medical Group0.034.444.40SERASera PrognosticsN/A2.022.02TALKTalkspaceN/A6.496.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFTREFortreaN/ASBCSBC Medical Group60.82%SERASera Prognostics54.64%TALKTalkspace57.37%Insider OwnershipCompanyInsider OwnershipFTREFortrea0.38%SBCSBC Medical Group89.47%SERASera Prognostics15.80%TALKTalkspace23.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFTREFortrea15,50090.50 million90.16 millionOptionableSBCSBC Medical GroupN/A103.61 million10.91 millionN/ASERASera Prognostics12037.67 million31.72 millionOptionableTALKTalkspace500167.32 million128.00 millionOptionableSERA, FTRE, TALK, and SBC HeadlinesRecent News About These CompaniesTalkspace's Earnings Power Is About To Become ObviousJuly 17, 2025 | seekingalpha.comTalkspace, Inc. (NASDAQ:TALK) Given Consensus Rating of "Buy" by BrokeragesJuly 17, 2025 | marketbeat.comCenterBook Partners LP Acquires 928,744 Shares of Talkspace, Inc. (NASDAQ:TALK)July 15, 2025 | marketbeat.com'Golden Bachelorette' star has an important message as 'Bachelor In Paradise' beginsJuly 11, 2025 | msn.comValeo Financial Advisors LLC Invests $1.30 Million in Talkspace, Inc. (NASDAQ:TALK)July 9, 2025 | marketbeat.comTALK | Talkspace Inc. Annual Cash Flow Statement - MarketWatchJuly 2, 2025 | marketwatch.comTalkspace, Inc. (TALK) Latest Stock News & Headlines - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comUnion Square-based youth mental health startup raises $12M on virtual care waveJune 30, 2025 | crainsnewyork.comCTalkspace, Inc. (NASDAQ:TALK) Given Consensus Recommendation of "Buy" by BrokeragesJune 22, 2025 | marketbeat.comInsider Selling: Talkspace, Inc. (NASDAQ:TALK) CMO Sells 39,000 Shares of StockJune 7, 2025 | insidertrades.comTalkspace to Participate in Upcoming Investor ConferencesJune 6, 2025 | globenewswire.comTalkspace And 2 Other Compelling Penny Stocks To ConsiderJune 5, 2025 | finance.yahoo.comShares of Talkspace Climb After Amazon Pharmacy PartnershipMay 29, 2025 | marketwatch.comNew York banning smart phones in schoolMay 18, 2025 | msn.comDigital health companies faced a rocky start to 2025May 9, 2025 | modernhealthcare.comMMental Health and Substance Misuse Treatment Is Increasingly a Video Chat or Phone Call AwayMay 9, 2025 | californiahealthline.orgC'Bachelor in Paradise' 2025: Palm Desert's Gary Levingston talks cast, Talkspace collabMay 9, 2025 | palmbeachpost.comPTalkspace: Great Value For A Tariff-Resistant BusinessMay 8, 2025 | seekingalpha.comEarnings call transcript: Talkspace Q1 2025 reports revenue growth, stock fallsMay 8, 2025 | uk.investing.comTalkspace First Quarter 2025 Earnings: EPS: US$0.002 (vs US$0.009 loss in 1Q 2024)May 8, 2025 | finance.yahoo.comNavigate Drives Continued Momentum in its Partner Ecosystem; Adds Talkspace, movr, and SpringbukMay 7, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSERA, FTRE, TALK, and SBC Company DescriptionsFortrea NASDAQ:FTRE$4.68 -0.02 (-0.32%) As of 11:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.SBC Medical Group NASDAQ:SBC$5.37 -0.28 (-4.96%) As of 11:04 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.Sera Prognostics NASDAQ:SERA$2.89 -0.03 (-0.96%) As of 11:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.Talkspace NASDAQ:TALK$2.56 +0.09 (+3.43%) As of 11:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
